Abbott pens blood-based Alzheimer’s testing pact with ALZpath
Novartis is paying $105m upfront to task Antares Therapeutics with generating small molecules against historically undruggable oncology targets.
H.B. Fuller, the largest adhesives company in the world, has made an offer to acquire Advanced Medical Solutions Group for $942m in cash.
Discreet biotech Osanni Bio starts making noise with $190M series B for clinical push
With $15M discovery deal, Boehringer becomes latest Big Pharma to buy into Immunai’s AI platform
Thalia Therapeutics is acquiring Sanmirna Therapeutics for an initial £3.6m and up to £13 million in milestone payments, adding the clinical-stage acute myeloid leukemia candidate miRisten
UK-based TRIMTECH Therapeutics has raised an additional $14 million, bringing its total seed financing to $47 million.
CroíValve, a pioneering medical device company focused on the development of a novel transcatheter device for the treatment of tricuspid regurgitation, announced the closing of $20m Series B expansion financing
Dutch biotech Leyden Labs has raised €40m from a group of investors to advance its nasal spray approach for protection against influenza and other respiratory viruses.
Ionis Pharmaceuticals has offloaded regional rights to its near-approval rare disease asset zilganersen, pocketing $30m upfront from Recordati for an ex-U.S. license to the drug candidate.
===============
Newton Colmore is a specialist search firm and we connect exceptional engineering and scientific talent with impactful companies, globally.